Functional studies on α1‐adrenoceptor subtypes mediating inotropic effects in rat right ventricle
Open Access
- 1 February 1994
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 111 (2) , 539-546
- https://doi.org/10.1111/j.1476-5381.1994.tb14771.x
Abstract
1 We have studied the α1-adrenoceptor subtypes mediating inotropic effects of adrenaline in rat right ventricle and the Ca2+ sources used to elicit these effects. (α1A-Adrenoceptor-mediated contractile effects in rat vas deferens were studied for comparison in some cases. 2 Treatment with chloroethylclonidine did not affect the maximal β-adrenoceptor-mediated inotropic effects in rat right ventricle or the maximal α1A-adrenoceptor-mediated contractile effects in rat vas deferens; it did not alter the potency of isoprenaline in the ventricle and reduced the potency of the α-adrenoceptor antagonists in vas deferens only slightly. Treatment of right ventricular strips with CdCl2 markedly reduced resting tension and enhanced maximal inotropic effects of isoprenaline but did not affect its potency. 3 Inactivation of cardiac α1B-adrenoceptors by treatment with chloroethylclonidine slightly enhanced the maximal inotropic effects of the. full agonist, adrenaline and of several partial agonists. 4 Schild analysis of inhibition experiments with the α1A-adrenoceptor-selective antagonists, 5-methylurapidil and (±)-tamsulosin, demonstrated that adrenaline causes its inotropic effects mainly via the α1B-adrenoceptor subtype. Schild analysis of 5-methyl-urapidil inhibition experiments in chloroethylclonidine-treated ventricles indicated that only α1A-adrenoceptors mediate the inotropic effects of adrenaline following inactivation of the α1B-adrenoceptors. 5 In control ventricles the organic Ca2+ entry blocker, nitrendipine and treatment with the inorganic Ca2+ entry blocker, CdCl2 did not reduce inotropic effects of adrenaline whereas ryanodine treatment inhibited them. In contrast, nitrendipine and CdCl2 treatment had major inhibitory effects in chloroethylclonidine-treated but lacked inhibitory effects in phenoxybenzamine-treated ventricular strips. 6 We conclude that inotropic effects of adrenaline in rat heart are mediated mainly by α1B-adrenoceptors via release of Ca2+ from an intracellular pool. Following inactivation of α1B-adrenoceptors by chloroethylclonidine treatment, α1A-adrenoceptors can fully compensate and mediate inotropic effects by promoting influx of extracellular Ca2+ at least partly via voltage-operated channels. Therefore, we speculate that α1B-adrenoceptors exert a tonic inhibitory effect on α1A-adrenoceptors.Keywords
This publication has 31 references indexed in Scilit:
- α‐ and β‐Adrenoceptors in Hypertension: Molecular Biology and Pharmacological StudiesBasic & Clinical Pharmacology & Toxicology, 1992
- Cardiac α1-adrenoceptors mediate positive inotropy via myofibrillar sensitizationTrends in Pharmacological Sciences, 1992
- Molecular biology of α-adrenergic receptors: implications for receptor classification and for structure-function relationshipsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1991
- Abnormal automatic rhythms in ischemic Purkinje fibers are modulated by a specific alpha 1-adrenergic receptor subtype.Circulation, 1991
- Function of myocardial α-adrenoceptorsLife Sciences, 1990
- Specific alpha 1-adrenergic receptor subtypes modulate catecholamine-induced increases and decreases in ventricular automaticity.Circulation Research, 1990
- α1-Adrenoceptors: the ability of various agonists and antagonists to discriminate between two distinct [3H]prazosin binding sitesJournal of Pharmacy and Pharmacology, 1989
- α1Adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscleNature, 1987
- NitrendipineDrugs, 1987
- Cellular Sodium Transport in Essential HypertensionNew England Journal of Medicine, 1986